caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1932146677

Philip FriedlanderM.D.

Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Philip Friedlander's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MOUNT SINAI HOSPITAL1450
Lale Kostakoglu Shields
Nuclear Medicine · Charlottesville, VA
1353
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
63
Beneficiaries
—
Total drug cost
$590K
Distinct drugs
5
Brand share
81.0%
Top prescribed drugs
Trametinib Dimethyl Sulfoxide14 claims
Dabrafenib Mesylate14 claims
Isavuconazonium Sulfate12 claims
Imatinib Mesylate12 claims
Vismodegib11 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
232
Unique beneficiaries
—
Total services
495
Distinct HCPCS
5
Medicare payment
$50K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.